Association of obesity on the outcome of critically ill patients affected by COVID-19.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Moreno, Gerard
- Diaz, Emili
- Ferre, Cristina
- Salgado, Melina
- Marin-Corral, Judith
- Estella, Angel
- Sole-Violan, Jordi
- Trefler, Sandra
- Socias, Lorenzo
- Borges-Sa, Marcio
- Restrepo, Marcos I
- Guardiola, Juan J
- Reyes, Luis F
- Albaya-Moreno, Antonio
- Berlanga, Alfonso Canabal
- Ortiz, Maria Del Valle
- Ballesteros, Juan Carlos
- Chinesta, Susana Sancho
- Laderas, Juan Carlos Pozo
- Gomez, Josep
- Bodi, Maria
- on behalf COVID-19/SEMCYUC Working group
Grupos
Abstract
OBJECTIVE: To evaluate the impact of obesity on ICU mortality. DESIGN: Observational, retrospective, multicentre study. SETTING: Intensive Care Unit (ICU). PATIENTS: Adults patients admitted with COVID-19 and respiratory failure. INTERVENTIONS: None. PRIMARY VARIABLES OF INTEREST: Collected data included demographic and clinical characteristics, comorbidities, laboratory tests and ICU outcomes. Body mass index (BMI) impact on ICU mortality was studied as (1) a continuous variable, (2) a categorical variable obesity/non-obesity, and (3) as categories defined a priori: underweight, normal, overweight, obesity and Class III obesity. The impact of obesity on mortality was assessed by multiple logistic regression and Smooth Restricted cubic (SRC) splines for Cox hazard regression. RESULTS: 5,206 patients were included, 20 patients (0.4%) as underweight, 887(17.0%) as normal, 2390(46%) as overweight, 1672(32.1) as obese and 237(4.5%) as class III obesity. The obesity group patients (n?=?1909) were younger (61 vs. 65 years, p?<?0.001) and with lower severity scores APACHE II (13 [9-17] vs. 13[10-17, p?<?0.01) than non-obese. Overall ICU mortality was 28.5% and not different for obese (28.9%) or non-obese (28.3%, p?=?0.65). Only Class III obesity (OR?=?2.19, 95%CI 1.44-3.34) was associated with ICU mortality in the multivariate and SRC analysis. CONCLUSIONS: COVID-19 patients with a BMI?>?40 are at high risk of poor outcomes in the ICU. An effective vaccination schedule and prolonged social distancing should be recommended.
Copyright © 2023 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 2173-5727, 2173-5727
- Tipo:
- Article
- Páginas:
- 142-154
Medicina intensiva
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- COVID-19; Obesidad; Obesity; Prognosis; Pronóstico
Proyectos asociados
PRIMAGE. PREDICTIVE IN-SILICO MULTISCALE ANALYTICS TO SUPPORT CANCER PERSONALIZED DIAGNOSIS AND PROGNOSIS, EMPOWERED BY IMAGING BIOMARKERS.
Investigador Principal: LUIS MARTÍ BONMATÍ
826494 . COMISION EUROPEA . 2018
PerProGlio. Integrative Personal Omics Profiles in Glioblastoma Recurrence and Therapy Resistance.
Investigador Principal: LUIS MARTÍ BONMATÍ
AC18/00077 . COMISION EUROPEA . 2019
Multicentre prospective study of diagnostic accuracy for quantification by Magnetic Resonance multiparametric imaging of liver fibrosis, inflammation, steatosis, iron and vascular resistance.
Investigador Principal: LUIS MARTÍ BONMATÍ
PI19/00380 . INSTITUTO DE SALUD CARLOS III . 2020
Modulating the activity of genes controlling fat metabolism as a therapeutic strategy in Huntington disease.
Investigador Principal: RAFAEL VÁZQUEZ MANRIQUE
PI20/00114 . INSTITUTO DE SALUD CARLOS III . 2021
Cita
Rodriguez A,Martin I,Moreno G,Diaz E,Ferre C,Salgado M,Marin J,Estella A,Sole J,Trefler S,Zaragoza R,Socias L,Borges M,Restrepo MI,Guardiola JJ,Reyes LF,Albaya A,Berlanga AC,Ortiz MV,Ballesteros JC,Chinesta SS,Laderas JCP,Gomez J,Bodi M,on behalf COVID G. Association of obesity on the outcome of critically ill patients affected by COVID-19. Med Intensiva (Engl Ed). 2023. 48. (3):p. 142-154.